Skip to content
About
Management
Board of Directors
Scientific Advisory Board
Therapeutic Areas
Pipeline
OLX07010 in Rare Tauopathies
OLX07010 Alzheimer’s
Technology
MOA
Patents
News & Publications
Partners and Collaborators
Contact Us
Menu
Oligomerix Inc. Awarded 2.49 Million Fast-Track
Home
>
News
>
Oligomerix Inc. Awarded 2.49 Million Fast-Track
Print
Oligomerix
>
News
>
Oligomerix Inc. Awarded 2.49 Million Fast-Track
Oligomerix Inc. Awarded 2.49 Million Fast-Track
Post navigation
Previous Post
Oligomerix, Inc. Awarded National Institute on Aging SBIR Grant for Development of Alzheimer’s Disease Specific Biomarker
Next Post
Oligomerix Relocates to Albert Einstein College of Medicine Campus
vera
View posts by vera
Leave a Reply
Cancel reply
You must be
logged in
to post a comment.
Scroll to top
close ×
